E-PREDICT: E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung Cancer

Sponsor
Radboud University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02488928
Collaborator
(none)
327
7
45
46.7
1

Study Details

Study Description

Brief Summary

EBUS elastography is a method to determine stiffness of lymph nodes, based on the minute deformation of the node by the beating heart. Whether EBUS elastography may further increase the sensitivity to predict the presence or absence of malignancy is unclear.

We suggest to use EBUS elastography strain pattern analysis for this assessment and correlate these measurements with the final pathology outcome to determine NPV, PPV, sensitivity and specificity of this analysis to predict the presence or absence of malignancy in patients with (suspected) lung cancer in a prospectively obtained observational cohort study.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients will undergo a routine EBUS and/or EUS or EUSb with Pentax series EBUS or EUS scopes in combination with Hitachi Preirus Hi-Vision ultrasound processor with installed elastography software. Normal international guidelines for staging, diagnosis and specimen acquisition will be followed. For a normal evaluation B-mode measurements from all lymph node regions are obtained assessing size and standard ultrasound characteristics and all lymph nodes in the regions of interest that meet the criteria for fine needle aspiration will be sampled. For this study, in addition to the normal B-mode assessment of five sonographic B-mode characteristics elastography strain graph video, elastography image, and a strain histogram from the region of interest will be obtained.

    Fine needle aspiration for cytology evaluation will be obtained from nodes based on imaging characteristics or standard sonography characteristics following current everyday clinical practice and the international guidelines. Subsequently, the patient charts will be retrospectively analysed after completion of the diagnostic and/or surgical treatment of the (suspected) lung cancer to match the obtained imaging data to pathology results (cytology and or histology where present) and clinical follow up until 6 months after the diagnostic procedure.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    327 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    E-PREDICT Evaluating the Predictive Value of EBUS ELASTOGRAPHY STRAIN in Patients With (Suspected) Lung Cancer
    Actual Study Start Date :
    Jul 1, 2015
    Actual Primary Completion Date :
    Jul 1, 2018
    Actual Study Completion Date :
    Apr 1, 2019

    Outcome Measures

    Primary Outcome Measures

    1. stiffness of lymph nodes [participants will be followed for the duration of hospital stay, an expected average of 4 hours]

      stiffness/strain is a relative measure and has therefor no units

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with indication for diagnostic or staging EBUS procedure for suspected or proven lung cancer.

    • ASA physical status 1-3.

    • Age 18 years or older.

    Exclusion Criteria:
    • Bleeding disorders.

    • Contra-indication for temporary interruption of the use of anticoagulant therapy (acenocoumarol, warfarin, therapeutic dose of low molecular weight heparines or clopidrogel).

    • Known allergy for lidocaine.

    • Uncontrolled pulmonary hypertension.

    • Recent and/or uncontrolled cardiac disease.

    • Compromised upper airway (eg concomitant head and neck cancer or central airway stenosis for any reason).

    • Prior radiotherapy treatment involving the central airways

    • ASA classification greater than or equal to 4.

    • Pregnancy.

    • Inability to consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rigshospitalet Copenhagen Denmark Dk 2100
    2 Interventional Pulmonology Unit Policlinico S. Orsola-Malpighi Bologna Italy 40138
    3 Azienda Ospedaliera Universitaria di Careggi Firenze Italy 50100
    4 Ausl Modena - Ospedale Santa Maria Bianca Modena Italy 41037
    5 Pesaro-Fano Hospital Pesaro Italy
    6 RadboudUMC Nijmegen Gelderland Netherlands 6500 HB
    7 Academic Medical Center Amsterdam Netherlands 1105 AZ

    Sponsors and Collaborators

    • Radboud University Medical Center

    Investigators

    • Principal Investigator: Erik van der Heijden, MD, PhD, chest physician

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Radboud University Medical Center
    ClinicalTrials.gov Identifier:
    NCT02488928
    Other Study ID Numbers:
    • 2015-1676
    First Posted:
    Jul 2, 2015
    Last Update Posted:
    Dec 16, 2019
    Last Verified:
    May 1, 2018
    Keywords provided by Radboud University Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 16, 2019